Trends in Bacteremic Infection Due to Streptococcus pyogenes (Group A Streptococcus), 1986-1995

Emerging Infectious Diseases

Volumn 2, Issue 1, 1996, Pages 54-56

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; HUMAN; ISOLATION AND PURIFICATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TIME;

BACTEREMIA; HUMANS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TIME FACTORS;

EID: 0029680826     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0201.960107     Document Type: Article

References (20)

1. Stevens DL. Streptococcal toxic shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infectious Diseases 1995; 1:69-78.
2. Stevens DL, Tanner MH, Winship J, et. al. Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome. N Engl J Med 1989; 321:1-7.
3. McGeer K, Green R, Cann D, et. al. Changing epidemiology of invasive group A streptococcal infection - population based surveillance, Ontario Canada, 1992-1995. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995; Abstract K135,
4. Cockerill F III, Thompson R, Roberson F, et. al. Outbreak of invasive group A streptococcal infections (ISI) in residents of southeastern Minnesota. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995; Abstract K137.
5. Levine OS, Turf E, Ginsberg R, et. al. An outbreak of invasive group A streptococcal disease in the Shenandoah Valley of Virginia. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995; Abstract K134.
6. Braunstein H. Characteristics of group A streptococcal bacteremia in patients at the San Bernardino County Medical Center. Rev Infect Dis 1991;13:8-11.
7. Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16:792-800.
8. Centers for Disease Control. Group A beta-hemolytic streptococcal bacteremia - Colorado, 1989. MMWR 1990;39:3-11.
9. Colorado Department of Health. Surveillance for group A streptococcal bacteremia in metropolitan Denver. Colo Dis Bull 1991;2:18.
10. Stromberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 1991;164:595-8.
11. Centers for Disease Control and Prevention. Invasive group A streptococcal infections - United Kingdom, 1994. MMWR 1994;43:401-2.
12. Burkert T, Watanakunakorn C. Group A streptococcal bacteremia in a community teaching hospital - 1980-1989. Clin Infect Dis 1992;14:29-37.
13. Hoge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 1993;269:384-9.
14. Ashkenazi S, Livni G, Leibovici L, et. al. Trends in incidence and severity of group A streptococcal (GAS) bacteremia. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995; Abstract K138.
15. Fleming C, Fisher E, Chang C, et. al. Studying outcomes and hospital utilization in the elderly. Med Care 1992; 30:377-91.
16. Holm SE, Norrby A, Bergholm A-M, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992;166:31-7.
17. Cleary PP, Kaplan EL, Handley JP, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992;339:518-21.
18. Talkington DF, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993;61:3369-74.
19. Musser JM, Kapur V, Kanjilal S, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expression allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993;167:337-46.
20. Musser JM, Nelson K, Selander RK, et al. Temporal variation in bacterial disease frequency: molecular population genetic analysis of scarlet fever epidemics in Ottawa and in Eastern Germany. J Infect Dis 1993;167:759-62.